Dr Matthew Streetly is a Consultant Haematologist appointed as clinical lead for myeloma/plasma cell disorders at Guys and St Thomas's NHS Foundation, and a member of the haemato-oncology inpatient attending team looking after inpatients with myeloma, lymphoma and leukaemia. He has a special interest in the use of novel therapies for patients with myeloma and is the principal investigator on multiple clinical trials.

Dr Streetly is a member of the UK myeloma forum guidelines writing group and a special trustee of the British Society of Haematology. He has published widely on myeloma and related disorders and is an invited speaker at national and international meetings.

Diseases, Medical Tests and Treatments

• Clinical trials for novel therapies for myeloma
• Myeloma diagnostics and biomarkers
• Haematology
• Myeloma and other plasma cell disorders (Amyloidosis, MGUS)
• Stem cell transplant
• Lymphoma